Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-22

Clinical Trial Update: Risperidone vs. Paroxetine for Panic Attacks [Phase 2]

View source ↗

Summary

Phase 2 trial comparing risperidone to paroxetine for panic attacks was terminated. The study enrolled patients with panic disorder and major depressive disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paroxetine (Paroxetine hydrochloride)
  • RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Major Depressive Disorder With Panic Attacks, Panic Disorder | Phase 2 | Status: TERMINATED